Top Midday Decliners

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Top Midday Decliners

, MT Newswires - 2:09 PM ET 3/20/2025 default

02:09 PM EDT, 03/20/2025 (MT Newswires) -- Akebia Therapeutics ( AKBA ) shares slid 28% amid heavy trading after the company said late Wednesday that it priced a public offering of $50 million common shares.

More than 22.2 million shares traded intraday compared with a daily average of about 2.72 million.

Cosciens Biopharma ( CSCI ) announced a possible delay overnight in filing year-end reporting documents, saying it may need additional time to address "certain matters" related to the 2024 all-stock merger with Ceapro.

Shares slumped 22% following an increase in intraday trading volume to over 70,000 from a daily average of about 24,000.

Yiren Digital ( YRD ) shares sank after the company reported Thursday a year-over-year decline in Q4 net income.

The decrease was primarily due to a growing loan volume facilitated by the company's risk model, which required upfront provisions and increased investment in acquiring higher-quality borrowers and developing AI capabilities, Yiren said.

Shares slid 20% as intraday trading volume rose to over 625,000 versus a daily average of about 136,000.

Price: 2.06, Change: -0.79, Percent Change: -27.64

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.